Navigation Links
Too Much Or Little Sleep Increases Risk Of Diabetes

According to a study by the New England Research Institutes in collaboration with Yale School of Medicine researchers men who sleep too much or too little// are at a greater risk of developing type II diabetes. The data originally published in March is based on studies done on over 1709 men, in the age groups of 40–70, the men were studied on over a period of 15 yrs.

According to the lead researcher Dr.H.Klar Yaggi, M.D., professor in Yale's Department of Internal Medicine, pulmonary section. It was found that men with 6-8 hrs sleep were most healthy. In Comparison men who stated that they slept between 5-6 hrs a night were twice as likely to develop diabetes, while those who slept for more than 8 hrs were three times at risk. The risks were the same after they had separated risk groups like, hypertension, smoking, etc.

With these studies he felt the researchers know beginning to understand the hormonal and metabolic implication sleep. As of now and the research he felt that men sleeping too little, are having marked alterations in the metabolic and hormonal functions including decreased carbohydrate tolerance, insulin resistance, and lower levels of the hormone leading to obesity. They are still studying the men with longer sleep durations. The studies are also trying to determine if disorders of sleep can also cause or worsen the metabolic syndrome.


'"/>




Page: 1

Related medicine news :

1. Little sleep as bad as no sleep
2. Aspirin Induced Asthma , A Little-Known Inducer
3. A Little Weight Loss Found To Make A Significant Difference In Men
4. Little Known DNA Repair Enzyme May Be A Tumor Suppressor Gene
5. Little Clinic LLC Plans Super Medical Clinics in Publix Super Markets
6. Trendsetters: Little girls fast track into ladies even before they know it
7. The Little Known Facts of Junk DNA
8. Diabetes Risk Pronounced With Too Much or Too Little Sleep
9. Reverse Heart Transplant Surgery On A Little Girl Makes History
10. Most People With Arthritis Do Little Or No Exercise At All
11. Little Makoda-Poster Girl For Leukemia Awareness Campaign Losses Her Battle Of Life
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2017)... ... June 26, 2017 , ... ... leakage is revolutionizing the way women look and feel about themselves and their ... of female sexual dysfunction and urinary leakage head on with a ground breaking ...
(Date:6/26/2017)... (PRWEB) , ... June 26, 2017 , ... KICKICO ... a whitepaper that pledges to solve many catastrophic issues within funding campaigns. KICKICO ... , The typical notion of crowdfunding - the raising of funds through the power ...
(Date:6/25/2017)... , ... June 24, 2017 , ... Create a feel-good lyric music video in Final ... and sound in the timeline and write in the lyrics to any song. ProLyric flies ... out. Each line of the text can be added modularly for optimal control. ProLyric makes ...
(Date:6/25/2017)... ... 2017 , ... CareSet Labs released the Root NPI Graph today at the ... greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. , ... called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released ...
(Date:6/24/2017)... Tampa, Fla. (PRWEB) , ... June 24, 2017 ... ... Fla., is now offering genetic testing for medications in select Florida and Texas ... of pharmacogenomics. , This new application of genetic testing recognizes the role ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... 2017 The Bio Supply Management Alliance (BSMA) ... Fremont and the Biomedical Manufacturing Network to ... California by providing a platform ... fostering workforce development. The primary focus of this alliance ... as well as small and mid-sized biomedical companies. ...
(Date:6/13/2017)... June 13, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that the U.S. Food and Drug Administration (FDA) has ... 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning Letter related ... facility is a measure of the progress we have made ...
(Date:6/11/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... studies of galcanezumab, an investigational treatment for the prevention ... several key secondary endpoints for galcanezumab compared to placebo ... (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today at ... Boston . "The ...
Breaking Medicine Technology: